Table of contents

Research Article

• Dynamic cardiomyoplasty for heart failure. (1 January, 1995)

  R. C. Chiu
• Cholesterol lowering does have a role in secondary prevention. (1 January, 1995)

  D. A. Wood
• Use of the implantable defibrillator. (1 January, 1995)

  S. C. Hammil, M. S. Stanton
• A New Year toast ... to the cardioprotective effects of alcohol. (1 January, 1995)

  M. J. Griffith
• Increased monocyte tissue factor expression in coronary disease. (1 January, 1995)

  E. W. Leatham, P. M. Bath, J. A. Tooze, A. J. Camm
• Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents. (1 January, 1995)

  K. Riesenberg, F. Schlaeffer, A. Katz, R. Levy
• Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. (1 January, 1995)

  H. J. Trappe, P. Pfitzner, H. Klein, P. Wenzlaff
• Vasoconstrictor peptides and cold intolerance in patients with stable angina pectoris. (1 January, 1995)

  P. A. Dodds, C. M. Bellamy, R. A. Muirhead, R. A. Perry
• QT dispersion and components of the QT interval in ischaemia and infarction. (1 January, 1995)

  P. D. Higham, S. S. Furniss, R. W. Campbell
• Increased dispersion of refractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. (1 January, 1995)

  R. G. Tieleman, H. J. Crijns, A. C. Wiesfeld, J. Posma, H. P. Hamer, K. I. Lie
• Activation and inhibition of the endogenous opioid system in human heart failure. (1 January, 1995)

  K. G. Oldroyd, C. E. Gray, R. Carter, K. Harvey, W. Borland, G. Beastall, S. M. Cobbe
• Morphological, haemodynamic, and clinical variables as predictors for management of isolated ventricular septal defect. (1 January, 1995)

  F. van den Heuvel, T. Timmers, J. Hess
• Doppler reconstruction of left ventricular pressure from functional mitral regurgitation: potential importance of varying orifice geometry. (1 January, 1995)

  H. B. Xiao, X. Y. Jin, D. G. Gibson
• Impairment of diastolic function during short-term anthracycline chemotherapy. (1 January, 1995)

  Y. Cottin, C. Touzery, B. Coudert, A. Gilles, P. Walker, J. L. Massing, M. Toubeau, A. Riedinger-Berriolo, D. Caillot, P. Louis
• Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. (1 January, 1995)

  M. Beghetti, W. Habre, B. Friedli, M. Berner
• Positron emission tomography with oxygen-15 of stunned myocardium caused by coronary artery vasospasm after recovery. (1 January, 1995)

  D. Agostini, H. Iida, A. Takahashi
• Haemochromatosis presenting as congestive cardiac failure. (1 January, 1995)

  J. Porter, N. Cary, P. Schofield
• Electrophysiology in a district general hospital. (1 January, 1995)

  A. Prakash, P. M. Holt
• Immediate and long-term clinical outcome of coronary angioplasty in patients aged 35 years or less. (1 January, 1995)

  M. J. Kofflard, P. P. de Jaegere, R. van Domburg, P. Ruygrok, M. van den Brand, P. W. Serruys, P. J. de Feyter
• Women and myocardial infarction: agism rather than sexism? (1 January, 1995)

  J. N. Adams, M. Jamieson, J. M. Rawles, R. J. Trent, K. P. Jennings
• Determinants of the length of stay in intensive care and in hospital after coronary artery surgery. (1 January, 1995)

  J. P. Mounsey, M. J. Griffith, D. W. Heaviside, A. H. Brown, D. S. Reid
• Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn. (1 January, 1995)

  J. C. Welch, J. M. Bridson, J. L. Gibbs